Maynard Um
-
-
-
-
-
-
-
Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 34c
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) call put ratio 1.5 calls to 1 put with a focus on July 7.5 calls and puts
-
-
-
-
-
-
-
Phathom Pharmaceuticals (PHAT) PT Lowered to $20 at H.C. Wainwright
-
-
-
-
-
-
-
Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 42c
-
-
-
-
-
-
-
Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 15c
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) Announces FDA Approval of VOQUEZNA
-
397,180 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

